# DESCRIPTION

## FIELD OF THE INVENTION

- relate to methods and products for rheumatoid arthritis treatment

## BACKGROUND TO THE INVENTION

- describe rheumatoid arthritis
- discuss current treatment options and limitations

## SUMMARY OF CERTAIN EMBODIMENTS OF THE INVENTION

- introduce novel biomarkers for predicting drug-free remission

## Example 1—Study Design

- define inclusion and remission criteria
- describe study design and sample size estimation
- outline prospective clinical variable assessment
- outline retrospective clinical variable assessment
- describe assessment of RA criteria
- describe healthy control participants
- describe CD4+ T cell isolation
- describe CD4+ T cell lysis
- describe peripheral blood mononuclear cell isolation
- describe serum separation and cell counting
- describe CD4+ purity check by flow cytometry

### Example 2—Clinical Data Results

- identify predictive clinical variables
- develop composite clinical biomarker score

## SUMMARY

- state association between remission and flare

## Example 3—Cytokine Results

- introduce cytokine results
- motivate biomarker development
- describe quality control measures
- detail logarithmic data transformation
- explain plate equilibration procedure
- perform baseline survival analysis
- conduct ROC analysis and biomarker threshold determination
- analyze longitudinal change in cytokine and chemokine levels
- summarize findings and implications

### Example 4—CD4+ T Cell RNAseq Results

- introduce patient samples
- describe CD4+ T cell isolation and processing
- summarize healthy control samples
- report RNA yield and integrity
- describe sequencing quality
- perform baseline analyses
- conduct univariate Cox regression
- perform multivariate Cox regression
- analyze ROC curves
- discuss results and conclusions

### Example 5—Integrative Analysis

- motivate integrative analysis
- perform variable selection
- apply Cox regression and ROC analysis
- discuss results and predictive performance

